Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson’s disease

International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

2003 • 7,170 citations

Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator

1991 • 2,982 citations

International union of pharmacology. XXII. Nomenclature for chemokine receptors.

2000 • 1,771 citations

An Essay on the Shaking Palsy

2002 • 1,658 citations

Control of microglial neurotoxicity by the fractalkine receptor

2006 • 1,422 citations

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.

1985 • 1,253 citations

Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease

2002 • 1,171 citations

An Essay on the Shaking Palsy

2002 • 1,151 citations

Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia

1998 • 1,118 citations

Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention

2003 • 1,065 citations

CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity

2001 • 1,024 citations

Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease

2003 • 616 citations

Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1995 • 608 citations

Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases

2004 • 487 citations

THE BRAIN-STEM LESIONS IN PARKINSONISM

1953 • 485 citations

Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease

2005 • 460 citations

CXCR4 Regulates Interneuron Migration in the Developing Neocortex

2003 • 441 citations

Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor

2002 • 413 citations

Inflammatory Process in Parkinsons Disease: Role for Cytokines

2005 • 406 citations

Expression of monocyte chemoattractant protein-1 and other β-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions

1998 • 400 citations

Chemokines

2003 • 391 citations

The chemokine SDF1 regulates migration of dentate granule cells

2002 • 383 citations

Expression of CX₃CR1 chemokine receptors on neurons and their role in neuronal survival

2000 • 375 citations

The Inflammatory Reaction Following 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Intoxication in Mouse

1999 • 372 citations

Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: Implications for Parkinson's disease

2002 • 366 citations

A Novel TNF Receptor Family Member Binds TWEAK and Is Implicated in Angiogenesis

2001 • 364 citations

Dopamine Transporter Is Required for In Vivo MPTP Neurotoxicity: Evidence from Mice Lacking the Transporter

1997 • 358 citations

Fractalkine modulates TNF-? secretion and neurotoxicity induced by microglial activation

2000 • 355 citations

Localization of fractalkine and CX₃CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia?

1998 • 334 citations

Production and neuroprotective functions of fractalkine in the central nervous system

2003 • 327 citations

The importance of inflammatory mechanisms in alzheimer disease

1998 • 325 citations

An inflammatory review of Parkinson’s disease

2002 • 318 citations

Characterization of chemokines and their receptors in the central nervous system: physiopathological implications

2002 • 314 citations

Critical role of microglial NADPH oxidase‐derived free radicals in the in vitro MPTP model of Parkinson's disease

2003 • 304 citations

Cytokines in Parkinson’s disease

2000 • 300 citations

Stromal Cell-Derived Factor 1α Mediates Neural Progenitor Cell Motility after Focal Cerebral Ischemia

2005 • 291 citations

MCP‐1 (CCL2) protects human neurons and astrocytes from NMDA or HIV‐tat‐induced apoptosis

2003 • 282 citations

Immunohistochemical Study of the β-Chemokine Receptors CCR3 and CCR5 and Their Ligands in Normal and Alzheimer's Disease Brains

1998 • 277 citations

Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1 and interleukin-1 in Wallerian degeneration

2005 • 271 citations

Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes

1985 • 270 citations

Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease

1999 • 263 citations

Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor‐α

2006 • 240 citations

Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism

2004 • 236 citations

A Chemokine, SDF-1, Reduces the Effectiveness of Multiple Axonal Repellents and Is Required for Normal Axon Pathfinding

2003 • 228 citations

Absence of MPTP-Induced Neuronal Death in Mice Lacking the Dopamine Transporter

1999 • 226 citations

Fractalkine and fractalkine receptors in human neurons and glial cells

2002 • 226 citations

Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP‐induced neurotoxicity: role of TNF‐α ¹

2006 • 219 citations

Rate of progression in Parkinson's disease: A 6‐[¹⁸F]fluoro‐L‐dopa PET study

2001 • 212 citations

The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice

1986 • 211 citations

6‐Hydroxydopamine‐induced alterations in blood–brain barrier permeability

2005 • 202 citations

Axonal sprouting following lesions of the rat substantia nigra

2000 • 201 citations

Fibroblast Growth Factor-Inducible-14 Is Induced in Axotomized Neurons and Promotes Neurite Outgrowth

2003 • 199 citations

The Mitogen-inducible Fn14 Gene Encodes a Type I Transmembrane Protein that Modulates Fibroblast Adhesion and Migration

1999 • 196 citations

Dextromethorphan Protects Dopaminergic Neurons against Inflammation-Mediated Degeneration through Inhibition of Microglial Activation

2003 • 195 citations

Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons

2002 • 193 citations

The Chemokine Fractalkine Inhibits Fas-Mediated Cell Death of Brain Microglia

2000 • 190 citations

Genetic ablation of tumor necrosis factor‐alpha (TNF‐α) and pharmacological inhibition of TNF‐synthesis attenuates MPTP toxicity in mouse striatum

2004 • 190 citations

Control of axon elongation via an SDF-1α/Rho/mDia pathway in cultured cerebellar granule neurons

2003 • 189 citations

Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain

2002 • 175 citations

To be or not to be (inflamed) – is that the question in anti-inflammatory drug therapy of neurodegenerative disorders?

2005 • 175 citations

A Cxcl12-Cxcr4 Chemokine Signaling Pathway Defines the Initial Trajectory of Mammalian Motor Axons

2005 • 172 citations

Highly regionalized neuronal expression of monocyte chemoattractant protein‐1 (MCP‐1/CCL2) in rat brain: Evidence for its colocalization with neurotransmitters and neuropeptides

2005 • 163 citations

The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system

2000 • 161 citations

Striatal Responses to Partial Dopaminergic Lesion: Evidence for Compensatory Sprouting

2000 • 161 citations

Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity

2005 • 153 citations

Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions.

1998 • 152 citations

Hypoxic-Ischemic Injury Induces Macrophage Inflammatory Protein-1α Expression in Immature Rat Brain

2002 • 144 citations

The Neurotoxicity of 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in the Monkey and Man

1984 • 142 citations

Differential strain susceptibility following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration acts in an autosomal dominant fashion: quantitative analysis in seven strains of Mus musculus

1999 • 140 citations

TWEAK Can Induce Pro-Inflammatory Cytokines and Matrix Metalloproteinase-9 in Macrophages

2004 • 138 citations

Fibroblast Growth Factor-Inducible 14 Mediates Multiple Pathways of TWEAK-Induced Cell Death

2003 • 135 citations

Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease

2006 • 133 citations

The Neurotoxin MPTP Causes Degeneration of Specific Nucleus A8, A9 and A10 Dopaminergic Neurons in the Mouse

1996 • 133 citations

The chemokine SDF-1 differentially regulates axonal elongation and branching in hippocampal neurons

2005 • 129 citations

Chemokines and their receptors in neurobiology: perspectives in physiology and homeostasis

2000 • 129 citations

Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: Functional effect of MCP‐1/CCL2 on calcium mobilization in primary cultured neurons

2005 • 129 citations

Tumor Necrosis Factor-Like Weak Inducer of Apoptosis-Induced Neurodegeneration

2004 • 125 citations

TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity

2002 • 125 citations

Towing of sensory axons by their migrating target cells in vivo

2004 • 124 citations

SDF‐1α‐mediated modulation of synaptic transmission in rat cerebellum

2000 • 123 citations

Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax

2004 • 121 citations

A Soluble Fn14-Fc Decoy Receptor Reduces Infarct Volume in a Murine Model of Cerebral Ischemia

2005 • 121 citations

Neuroprotective activity of chemokines against N-methyl-d-aspartate or β-amyloid-induced toxicity in culture

2000 • 117 citations

Viewing chemokines as a third major system of communication in the brain

2005 • 116 citations

Apoptotic mechanisms and antiapoptotic therapy in the MPTP model of Parkinson's disease

2003 • 114 citations

Expression of the chemokine receptor Cxcr4 mRNA during mouse brain development

2004 • 113 citations

Spontaneous Regeneration of Nigrostriatal Dopaminergic Neurons in MPTP-Treated C57BL/6 Mice

1998 • 110 citations

Influence of interleukin-1β gene polymorphisms on age-at-onset of sporadic Parkinson's disease

2000 • 106 citations

Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats

2003 • 104 citations

Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 are involved in both excitotoxin-induced neurodegeneration and regeneration

2004 • 103 citations

MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson’s disease: neuroprotective strategies

2000 • 102 citations

Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease

2002 • 101 citations

Macrophage inflammatory protein-1α(MIP-1α), MIP-1β, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions

2000 • 101 citations

Brain Cytokines and Chemokines: Roles in Ischemic Injury and Pain

2006 • 98 citations

Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson’s disease

2006 • 91 citations

Chemokines and Brain Functions

2005 • 89 citations

Role of TNF-α Receptors in Mice Intoxicated with the Parkinsonian Toxin MPTP

2002 • 88 citations

Increased vulnerability of dopaminergic neurons in MPTP‐lesioned interleukin‐6 deficient mice

2002 • 87 citations

Acetaminophen and aspirin inhibit superoxide anion generation and lipid peroxidation, and protect against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats

2003 • 84 citations

Neuroglial responses to the dopaminergic neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse striatum

1995 • 80 citations

Parkinson's disease and inflammatory changes

2003 • 78 citations

Absence of Macrophage-Inflammatory Protein-1α Delays Central Nervous System Demyelination in the Presence of an Intact Blood-Brain Barrier

2001 • 77 citations

Chemokine Signaling Guides Axons within the Retina in Zebrafish

2005 • 77 citations

Interaction of polymorphisms in the genes encoding interleukin‐6 and estrogen receptor beta on the susceptibility to Parkinson's disease

2005 • 76 citations

Chemokine antagonist infusion promotes axonal sparing after spinal cord contusion injury in rat

2001 • 75 citations

Dexamethasone Downregulates Chemokine Receptor CXCR4 and Exerts Neuroprotection against Hypoxia/Ischemia-Induced Brain Injury in Neonatal Rats

2004 • 70 citations

cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: implications for idiopathic Parkinson’s disease

2000 • 69 citations

Dynamics of production of MIP-1α, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats

1999 • 68 citations

Salicylate protects against MPTP-induced impairments in dopaminergic neurotransmission at the striatal and nigral level in mice

1999 • 67 citations

Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxin

2003 • 66 citations

Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease

2004 • 66 citations

Induction of macrophage inflammatory protein MIP-1α mRNA on glial cells after focal cerebral ischemia in the rat

1997 • 66 citations

Clustering of cytokine genes on mouse chromosome 11.

1990 • 66 citations

Functional promoter region polymorphism of the proinflammatory chemokine IL-8 gene associates with Parkinson's disease in the Irish

2004 • 65 citations

Ablation of the chemokine monocyte chemoattractant protein-1 delays retrograde neuronal degeneration, attenuates microglial activation, and alters expression of cell death molecules

2002 • 63 citations

Stimulation of chemokine CXC receptor 4 induces synaptic depression of evoked parallel fibers inputs onto Purkinje neurons in mouse cerebellum

2002 • 62 citations

Stromal cell‐derived factor‐1α modulation of the excitability of rat substantia nigra dopaminergic neurones: presynaptic mechanisms

2006 • 62 citations

The SDF‐1/CXCR4 pathway and the development of the cerebellar system

2005 • 62 citations

Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse

2001 • 61 citations

Compromised reactive microgliosis in MPTP-lesioned IL-6 KO mice

2003 • 61 citations

Glia cell number modulates sensitivity to MPTP in mice

2005 • 60 citations

Early and specific expression of Monocyte Chemoattractant Protein-1 in the thalamus induced by cortical injury11Published on the World Wide Web on 25 May 2000.

2000 • 58 citations

Parkinson's disease risk factors: genetic, environmental, or both?

2005 • 58 citations

Complex effects of stromal cell‐derived factor‐1α on melanin‐concentrating hormone neuron excitability

2005 • 57 citations

[¹⁸F]FDOPA and [¹⁸F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease

2001 • 56 citations

Superoxide Dismutase 1 Overexpression Reduces MCP-1 and MIP-1α Expression after Transient Focal Cerebral Ischemia

2005 • 55 citations

DNA array reveals altered gene expression in response to focal cerebral ischemia

2002 • 54 citations

Proteomic analysis of microglial contribution to mouse strain–dependent dopaminergic neurotoxicity

2006 • 54 citations

Strain-dependent recovery of open-field behavior and striatal dopamine deficiency in the mouse MPTP model of Parkinson’s disease

1999 • 53 citations

TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules

2006 • 52 citations

Chemokines and Their Receptors in Central Nervous System Disease

2006 • 52 citations

Increased chemokine gene expression during aging in the murine brain

2001 • 51 citations

Strain‐dependent susceptibility to MPTP and MPP⁺‐induced Parkinsonism is determined by glia

2001 • 51 citations

Chemokine regulation of macrophage recruitment into the olfactory epithelium following target ablation: Involvement of macrophage inflammatory protein‐1α and monocyte chemoattractant protein‐1

2002 • 46 citations

Functional SDF1α/CXCR4 signaling in the developing spinal cord

2005 • 45 citations

Demonstration of autoreceptors on dopamine neurons in different brain regions of rats treated with gammabutyrolactone

1983 • 44 citations

Tumor necrosis factor-alpha receptor ablation in a chronic MPTP mouse model of Parkinson's disease

2004 • 44 citations

PET studies of functional compensation in a primate model of Parkinsonʼs disease

1997 • 44 citations

Sprouting of Dopaminergic Axons after Striatal Injury: Confirmation by Markers Not Dependent on Dopamine Metabolism

1999 • 42 citations

Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson's disease

2003 • 38 citations

Effects of cytokine deficiency on chemokine expression in CNS of mice with EAE

2002 • 36 citations

Nonsteroidal Anti-inflammatory Drugs Protect Against Parkinson Neurodegeneration

2003 • 34 citations

Significant up-regulation of nestin protein in the neostriatum of MPTP-treated mice

2002 • 33 citations

Acute ultrastructural effects of MPTP on the nigrostriatal pathway of the C57BL/6 adult mouse: Evidence of compensatory plasticity in nigrostriatal neurons

2000 • 30 citations

Identification of a single QTL, Mptp1, for susceptibility to MPTP-induced substantia nigra pars compacta neuron loss in mice

2003 • 29 citations

Increase of Striatal Dopamine Turnover by Stress in MPTP-Treated Mice

1988 • 24 citations

Environment, Genetics and Idiopathic Parkinson's Disease

1991 • 23 citations

Elevation Of Striatal Interleukin‐6 and Serum Corticosterone Contents In Mptp‐Treated Mice

1999 • 23 citations

Expression and distribution of CC chemokine macrophage inflammatory protein-1α/LD78 in the human brain

1997 • 22 citations

MPP+ can disrupt the nigrostriatal dopamine system by acting in the terminal area

1986 • 21 citations

Interactions Between Environmental and Genetic Factors in the Pathophysiology of Parkinson's Disease

2003 • 18 citations

Injury and strain-dependent dopaminergic neuronal degeneration in the substantia nigra of mice after axotomy or MPTP

2003 • 14 citations

Target ablation-induced regulation of macrophage recruitment into the olfactory epithelium ofMip-1α^−/−mice and restoration of function by exogenous MIP-1α

2004 • 13 citations